Christopher Viehbacher, chief executive officer at global pharmaceutical firm Sanofi-Aventis, will deliver the opening keynote address at the annual Council for Entrepreneurial Development’s Life Science Conference in Raleigh.

Viehbacher was a longtime senior executive officer at GlaxoSmithKline. He took over as CEO at Sanofi after Andrew Witty was named CEO in 2008.

The two-day event is scheduled at the Raleigh Convention Center. Viehbacher speaks shortly after 1 p.m.

The conference also will include a showcase of start-up and emerging companies.

Presenting companies include:


  • Aerial BioPharma LLC
  • Chimerix, Inc.
  • CoLucid Pharmaceuticals, Inc.
  • Heat Biologics
  • Liquidia Technologies
  • SCYNEXIS, Inc.
  • Vascular Pharmaceuticals, Inc.
  • Viamet Pharmaceuticals, Inc.


  • Advanced Animal Diagnostics, Inc.
  • Advanced Liquid Logic, Inc.
  • Clearside Biomedical, Inc.
  • Humacyte
  • Metabolon, Inc.
  • nContact, Inc.
  • TearScience
  • TransEnterix, Inc.

For conference agenda, read here.

Get the latest news alerts: Follow WRAL Tech Wire at Twitter.